Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iSpecimen (ISPC) Shares Outstanding (Diluted Average) (2020 - 2025)

iSpecimen has reported Shares Outstanding (Diluted Average) over the past 6 years, most recently at $4.6 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Diluted Average) at $4.6 million for Q4 2025, up 547.46% from a year ago — trailing twelve months through Dec 2025 was $4.6 million (up 547.46% YoY), and the annual figure for FY2025 was $4.6 million, up 547.46%.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $4.6 million at iSpecimen, down from $5.8 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Diluted Average) for ISPC hit a ceiling of $9.0 million in Q2 2023 and a floor of $452067.0 in Q4 2023.
  • Median Shares Outstanding (Diluted Average) over the past 5 years was $3.3 million (2021), compared with a mean of $4.3 million.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): tumbled 94.92% in 2024 and later surged 923.24% in 2025.
  • iSpecimen's Shares Outstanding (Diluted Average) stood at $4.3 million in 2021, then soared by 106.28% to $8.8 million in 2022, then tumbled by 94.89% to $452067.0 in 2023, then soared by 57.24% to $710852.0 in 2024, then skyrocketed by 547.46% to $4.6 million in 2025.
  • The last three reported values for Shares Outstanding (Diluted Average) were $4.6 million (Q4 2025), $5.8 million (Q3 2025), and $2.4 million (Q2 2025) per Business Quant data.